Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | MDGL | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Madrigal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.00 | 522.30 | 505.55 | ||
| High | 186.12 | 528.96 | 510.55 | ||
| Low | 176.60 | 521.80 | 447.01 | ||
| Last | 185.50 | 525.82 | 493.11 | ||
| Change | +4.71 | +1.12 | -53.77 | ||
| Percent Change | +2.61% | +0.21% | -9.83% | ||
| Volume | 2,171,700 | 472,400 | 1,487,700 | ||
| 20-Day Average Volume | 1,162,945 | 395,120 | 343,455 | ||
| Previous | 180.79 | 524.70 | 546.88 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 176.13 | 536.59 | 541.01 | ||
| 20-Day Raw Stochastic | 96.53% | 17.81% | 37.65% | ||
| 20-Day Relative Strength | 65.59 | 42.72 | 42.26 | ||
| Weighted Alpha | +52.34 | +46.68 | +40.90 | ||
| Today's Opinion | 100% Buy | 24% Sell | 16% Buy | ||
| Yesterday's Opinion | 100% Buy | 24% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.52% since 07/23/26 | -0.70% since 07/23/26 | -9.25% since 07/23/26 | ||
| Low | 173.43 on 07/24/26 | 517.61 on 07/29/26 | 447.01 on 07/30/26 | ||
| High | 186.12 on 07/30/26 | 537.76 on 07/24/26 | 566.18 on 07/27/26 | ||
| 1-Month | |||||
| %Chg | +10.07% since 06/30/26 | -2.95% since 06/30/26 | -8.16% since 06/30/26 | ||
| Low | 165.91 on 07/01/26 | 517.61 on 07/29/26 | 447.01 on 07/30/26 | ||
| High | 186.12 on 07/30/26 | 563.70 on 07/07/26 | 569.44 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +40.88% since 04/30/26 | -7.97% since 04/30/26 | -4.69% since 04/30/26 | ||
| Low | 129.86 on 05/01/26 | 517.61 on 07/29/26 | 445.20 on 06/03/26 | ||
| High | 186.12 on 07/30/26 | 609.35 on 05/06/26 | 569.44 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | +36.34% since 01/30/26 | +12.00% since 01/30/26 | +0.78% since 01/30/26 | ||
| Low | 122.14 on 02/12/26 | 464.44 on 02/11/26 | 416.21 on 03/03/26 | ||
| High | 186.12 on 07/30/26 | 609.35 on 05/06/26 | 572.20 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,178,436 | 22,271,938 | 12,608,860 | ||
| Shares Outstanding, K | 100,550 | 42,447 | 23,056 | ||
| Annual Sales, $M | 2,860,500,000 | 3,182,700,000 | 958,400,000 | ||
| Annual Net Income, $M | 478,600,000 | 1,334,700,000 | -288,280,000 | ||
| Last Qtr Sales, $M | 814,500,000 | 781,500,000 | 311,340,000 | ||
| Last Qtr Income, $M | 197,900,000 | 274,900,000 | -94,390,000 | ||
| 60-Month Beta | 0.39 | 0.58 | -1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.94 on 05/05/26 | 5.82 on 05/06/26 | -3.25 on 05/06/26 | ||
| Latest Earnings Date | 07/30/26 | 08/05/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 30.78 | 19.33 | 0.00 | ||